Sanofi/Wilkes Industry Fellowship Program

首页 - 学者 - 内斯比特药学院 - Sanofi / Wilkes Pharmaceutical Industry Fellowship Program

The Sanofi and 推荐全球十大博彩公司排行榜 two-year Pharmaceutical Industry Fellowship Program offers Doctor of Pharmacy graduates a comprehensive experience. 该计划提供 opportunities in various functional areas within multiple Global Business Units.

提供的奖学金

药物警戒奖学金

The Fellow will have the opportunity to rotate across the various Sanofi Global Business Units within Pharmacovigilance.

药物警戒奖学金

美国医疗事务奖学金

The Fellow will have the opportunity to rotate across Sanofi 疫苗 in multiple Medical Affairs areas, such as Field-Based Medical Team (Medical Science Liaison), Medical Strategy, Health Economics and Outcomes, and Omnichannel.

美国医疗事务奖学金

Periodic Safety Reports 与文献监测 Fellowship

The Fellow will have the opportunity to develop expertise in various pharmacovigilance operational activities including Periodic Safety Report (PSR) planning, PSR coordination 与文献监测.

PERIODIC SAFETY REPORTS AND LITERATURE Surveillance FELLOWSHIP

公司概述

Around the 世界, more than 100,000 people at Sanofi are dedicated to chasing the miracles of science to improve people’s lives. Our promise to our employees is to pursue progress and discover extraordinary together: better science, better medications, 更好的结果. All that progress needs people. People from diverse backgrounds, in various places around the 世界, performing distinct roles all united by one thing: a desire to chase the miracles of science to improve people’s lives.

我们的员工是:

探索更多的, sharing our purpose and our skills.
追求变化 接受创新的想法.
做正确的 for our business, patients, society, and the planet. We are committed to making the right decision and taking action even when it is the harder thing to do.
创造奇迹, taking thoughtful risks to find better solutions for the people we serve.

对赛诺菲

Sanofi is structured with four Global Business Units to support the company’s Play 取胜策略:

专业护理
疫苗
一般的药物
Consumer Healthcare (a standalone business unit)

截至2023年4月，R&D管道包含:

78个项目
24 projects are in phase 3 or have been submitted to regulatory authorities for approval

We are committed to high standards of manufacturing excellence and our people produce healthcare solutions to prevent and manage a broad spectrum of medical conditions.

Approximately 34,000 people involved
67个生产基地
4人以上.8 billion units of pharmaceuticals, consumer healthcare and vaccines, including in-house and outsourced production were sold in 2021

我们的疫苗之旅

Sanofi has been a leader in vaccines for 超过100年. The combination of our innovative vaccines and global reach means that many diseases do not hold the power they once did. Our determination to improve public health motivates us to develop new vaccines to address still unmet medical needs.

Fueled by new data and digital technologies, our science and manufacturing have the potential to transform the practice of medicine for millions of people around the 世界. And when we discover the extraordinary, we’re already planning where to go 下一个. Because everyone deserves a chance to plan for their future, to dream big.

我们的疫苗在 ~ 150个国家

5亿年 people vaccinated annually with our vaccines, 世界wide

2.500万年 vaccine doses supplied, every day

€5亿 投资于疫苗&D每年

我们的专业护理之旅

As the 专业护理 Global Business Unit of Sanofi, our work is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the 世界.

专业护理 focuses on developing transformative specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients 以及他们的家人.

We are driven by our patient-focused science led approach and our ambition is to be the industry leader in 专业护理. 我们目前提供 25次以上治疗 to patients globally, with many potential new therapies being studied in clinical trials and in Sanofi laboratories. This is made possible by the significant expertise of market access professionals in countries and globally who are passionate about 他们的使命.